Heterogeneous treatment effect of dose‐dense paclitaxel plus carboplatin therapy for advanced ovarian cancer
Ayumi Taguchi(Tokyo Metropolitan Komagome Hospital), Aikou Okamoto(Jikei University School of Medicine), Konan Hara(University of Arizona), Kyosuke Yamada(Jikei University School of Medicine), Akiko Furusawa(Tokyo Metropolitan Komagome Hospital), Hiroaki Kajiyama(Nagoya University), Muneaki Shimada(Tokyo Metropolitan Ohtsuka Hospital), Kenbun Sone(University of Tokyo Hospital), Kosuke Kato(The University of Tokyo)
Cited by 5
Related Papers
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
|Nature Medicine|2004|517
Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals
|Journal of Virology|1990|327
High Incidence of Urinary JC Virus Excretion in Nonimmunosuppressed Older Patients
|The Journal of Infectious Diseases|1990|238
Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
|Scientific Reports|2017|139
Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair
|Nature Communications|2014|109